Exemplar Hospital Initiation Trial to Enhance Treatment Engagement (EXHIT ENTRE) (NIH HEAL Initiative)

Funded by the NIH HEAL Initiative®

This study will examine whether 1) in hospitals with addiction medicine consultation services, hospital-initiated extended release buprenorphine (XR-BUP), compared to other OUD medications, results in increased OUD treatment engagement following hospital discharge; and 2) training hospitals without such consultation services on best practices for initiating OUD medication using consultation service hubs improves medication uptake in hospitals and following discharge.

NCT04345718

Gavin Bart, M.D., Ph.D., FACP, FASAM

Director, Addiction Medicine

Minneapolis Medical Research Foundation

Hennepin County Medical Center

701 Park Avenue G5, Minneapolis, MN, 55415, US

bartx005@umn.edu

Richard Saitz, MD, MPH, FACP, DFASAM

Chair, Department of Community Health Sciences

Boston University School of Public Health

801 Massachusetts Ave., 4th Floor, Boston, MA, 02118, US

rsaitz@bu.edu

CTN-0098 active